Prime Therapeutics · 12 hours ago
Financial Analyst Sr - Remote
United States
Full-time
Remote
Senior Level
$74K/yr - $118K/yr
5+ years expPrime Therapeutics is a different kind of PBM focused on connecting care for those they serve. The Senior Financial Analyst will provide leadership on financial analysis and reporting related to profitability, direct budgeting and forecasting processes, and support financial requirements across departments.
Health CarePharmaceutical
No H1B
Responsibilities
Provide financial leadership and direction to various Prime departments on the annual budget, forecast, and monthly financial requirements
Provide trend analysis on key issues including capital planning and projects
Recommend operational improvements after investigating, and analyzing data from a financial and functional view
Provide mentoring to junior members of the FP&A team
Other duties as assigned
Qualification
Required
Bachelor's degree in Accounting or Finance or related area of study, or equivalent combination of education and/or relevant work experience; HS diploma or GED is required
5 years of experience in accounting and/or financial analysis
Must be eligible to work in the United States without need for work visa or residency sponsorship
Strong team player with effective communication and presentation skills as well as a customer service approach
Very strong analytical skills and attention to detail, with experience in working in complex environments
Ability to adapt and multi-task
Preferred
MBA in Finance or related field
Advanced level experience in Excel, Word, and PowerPoint; experience creating complex formulas
PBM, Healthcare, Contact Center, Government Programs, knowledge and/or experience
Experience working with databases to retrieve and analyze data
Company
Prime Therapeutics
Prime Therapeutics is a trusted pharmacy solutions partner delivering savings, simplicity & support to our customers and members
5001-10000 employees
Funding
Current Stage
Late StageLeadership Team
Mostafa Kamal
President & Chief Executive Officer
Kenneth Bodmer
Chief Financial Officer
Recent News
2025-10-31
Company data provided by crunchbase